Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
7,411.00
-155.00 (-2.05%)
Jun 19, 2026, 11:30 AM JST

Chugai Pharmaceutical Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Chugai Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥9,973. The average 1-year stock price forecast is 34.57% higher than the current stock price, while the lowest is ¥8,000 (+7.95%) and the highest is ¥13,500 (+82.16%).

Price Target: ¥9,973 (+34.57%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price¥8,000¥9,973¥9,800¥13,500
Change+7.95%+34.57%+32.24%+82.16%

Analyst Ratings

The average analyst rating for Chugai Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy555555
Buy444444
Hold555666
Sell111000
Strong Sell000000
Total151515151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Nomura
No rating
Nomura
Hold
Maintains
¥8,200¥8,000
HoldMaintains¥8,200¥8,000+7.95%Jun 3, 2026
Unknown Analyst
Mizuho Securities
No rating
Mizuho Securities
Hold
Maintains
¥10,000¥8,250
HoldMaintains¥10,000¥8,250+11.32%May 29, 2026
Unknown Analyst
J.P. Morgan
No rating
J.P. Morgan
Buy
Maintains
¥11,000
BuyMaintains¥11,000+48.43%May 27, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Hold
Maintains
¥8,800
HoldMaintains¥8,800+18.74%May 26, 2026
Jefferies
Jefferies
Hold
Maintains
¥9,100¥8,500
HoldMaintains¥9,100¥8,500+14.69%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.39T
from 1.26T
Increased by 10.26%
Revenue Next Year
1.54T
from 1.39T
Increased by 10.68%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
999.76B1.26T1.11T1.17T1.26T1.39T
Revenue Growth
27.04%26.03%-11.79%5.33%7.46%10.26%
Gross Profit
661.61B783.70B698.06B831.20B894.25B1.01T
Gross Margin
66.18%62.20%62.81%71.01%71.09%73.14%
Operating Income
421.90B533.31B439.17B542.00B598.83B701.24B
Net Income
303.00B374.43B325.47B387.32B434.01B510.64B
Dividend / Share
76.0078.0080.0098.00122.00136.62
Dividend Growth
-2.63%2.56%22.50%24.49%11.98%
Free Cash Flow
177.70B148.16B317.04B338.82B263.05B461.21B
No. Analysts
-----14
Financial currency is JPY.

Revenue Forecast

Revenue202620272028
High1.4T
Avg1.4T
Low1.4T

Revenue Growth

Revenue Growth202620272028
High
14.6%
Avg
10.3%
Low
8.4%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-